Prostate Pain Syndrome—Treatment Options

[1]  W. Weidner,et al.  105: The Efficacy of Cernilton® in Patients with Chronic Pelvic Pain Syndrome (CP/CPPS) Type Nih IIIA: A Randomized, Prospective, Double-Blind, Placebo Controlled Study , 2006 .

[2]  E. Rowe,et al.  A prospective, randomized, placebo controlled, double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. , 2005, The Journal of urology.

[3]  E. Cornel,et al.  The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. , 2005, European urology.

[4]  G. Sant,et al.  Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. , 2005, The Journal of urology.

[5]  J. Wilson,et al.  The response to sertraline in men with chronic pelvic pain syndrome , 2005, Sexually Transmitted Infections.

[6]  C. Jantos,et al.  Chronic prostatitis: A thorough search for etiologically involved microorganisms in 1,461 patients , 2005, Infection.

[7]  J. Krieger,et al.  Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. , 2004, Urology.

[8]  M. Pontari,et al.  Ciprofloxacin or Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome , 2004, Annals of Internal Medicine.

[9]  W. Weidner.  Treating Chronic Prostatitis: Antibiotics No, -Blockers Maybe , 2004, Annals of Internal Medicine.

[10]  M. Pontari,et al.  A randomized placebo‐controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis) , 2004, BJU international.

[11]  P. Narayan,et al.  Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. , 2004, The Journal of urology.

[12]  P. Chiang,et al.  Therapeutic effect of transurethral needle ablation in non‐bacterial prostatitis: Chronic pelvic pain syndrome type IIIa , 2004, International journal of urology : official journal of the Japanese Urological Association.

[13]  F. Gallo,et al.  Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. , 2004, Urology.

[14]  H. Hossain,et al.  The 2001 Giessen Cohort Study on patients with prostatitis syndrome – an evaluation of inflammatory status and search for microorganisms 10 years after a first analysis , 2003, Andrologia.

[15]  J. Nickel,et al.  Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. , 2003, Urology.

[16]  D. Schmid,et al.  A new high frequency electrostimulation device to treat chronic prostatitis. , 2003, The Journal of urology.

[17]  J. Nickel,et al.  Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. , 2003, Urology.

[18]  J. Turner,et al.  Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case-control study. , 2003, The Journal of urology.

[19]  H. Danuser,et al.  Non-inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy. , 2003, European urology.

[20]  B. Lobel,et al.  Chronic prostatitis: what we know, what we do not know, and what we should do! , 2003, World Journal of Urology.

[21]  P. Hellström,et al.  Mechanisms of pain in chronic pelvic pain syndrome: influence of prostatic inflammation , 2003, World Journal of Urology.

[22]  J. Potts.  Chronic pelvic pain syndrome: a non-prostatocentric perspective , 2003, World Journal of Urology.

[23]  M. Pontari,et al.  A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. , 2003, The Journal of urology.

[24]  A. Schaeffer,et al.  Summary consensus statement: Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome , 2003 .

[25]  J. Krieger,et al.  Chronic Prostatitis: Role of Uncommon Organisms , 2003 .

[26]  K. Naber.  Antimicrobial Treatment of Bacterial Prostatitis , 2003 .

[27]  J. Nickel.  Clinical Evaluation of the Patient Presenting with Prostatitis , 2003 .

[28]  G. Barbalias.  Why Alpha-Blockers in Prostatitis? , 2003 .

[29]  J. Potts.  Alternative Approaches to the Management of Prostatitis: Biofeedback, Progressive Relaxation and the Concept of Functional Somatic Syndromes , 2003 .

[30]  A. Schaeffer,et al.  Common organisms in urogenital infections with special impact on prostatitis. Discussion , 2003 .

[31]  M. Pontari.  Inflammation and anti-inflammatory therapy in chronic prostatitis , 2002 .

[32]  A. Young,et al.  A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder. , 2002, The Journal of clinical psychiatry.

[33]  T. Tammela,et al.  Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study. , 2002, Urology.

[34]  J.G. Lee,et al.  Transurethral needle ablation for chronic nonbacterial prostatitis , 2002, BJU international.

[35]  D. Vigo,et al.  Effects of mepartricin on estradiol and testosterone serum levels and on prostatic estrogen, androgen and adrenergic receptor concentrations in adult rats. , 2001, Pharmacological research.

[36]  J. Nickel,et al.  Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. , 2001, The Journal of urology.

[37]  A. Hemal,et al.  Infundibulopelvic anatomy and clearance of inferior caliceal calculi with shock wave lithotripsy. , 2000, The Journal of urology.

[38]  A. Schaeffer,et al.  Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. , 2000, The Journal of urology.

[39]  J. Rajfer,et al.  Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. , 1999, Urology.

[40]  M. Pontari,et al.  The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure , 1999 .

[41]  J. Krieger,et al.  NIH consensus definition and classification of prostatitis. , 1999, JAMA.

[42]  P. Boyle,et al.  Double‐blind, placebo‐controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH , 1998, The Prostate.

[43]  T. B. Bjerklund Johansen,et al.  The Role of Antibiotics in the Treatment of Chronic Prostatitis:A Consensus Statement , 1998, European Urology.

[44]  J. Nickel.  Effective office management of chronic prostatitis. , 1998, The Urologic clinics of North America.

[45]  Mayersak Js.  Transrectal ultrasonography directed intraprostatic injection of gentamycin-xylocaine in the management of the benign painful prostate syndrome. A report of a 5 year clinical study of 75 patients. , 1998 .

[46]  E. Nagy,et al.  The possible role of anaerobic bacteria in chronic prostatitis. , 1998, International journal of andrology.

[47]  G. Nikiforidis,et al.  Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. , 1998, The Journal of urology.

[48]  B. Hennenfent,et al.  Changes in white blood cell counts in men undergoing thrice-weekly prostatic massage, microbial diagnosis and antimicrobial therapy for genitourinary complaints. , 1998, British journal of urology.

[49]  N. Webster,et al.  Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis. , 1997, Critical care medicine.

[50]  H. Meyhoff,et al.  Chronic prostatic pain. A new treatment option with finasteride? , 1997, Scandinavian journal of urology and nephrology.

[51]  J. Krieger,et al.  Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis , 1996, Journal of clinical microbiology.

[52]  S. Watanabe,et al.  Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells. , 1996, Chemotherapy.

[53]  J. Heiman,et al.  Psychological and physical factors involved in chronic idiopathic prostatitis. , 1996, Journal of psychosomatic research.

[54]  A L Gould,et al.  Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials. , 1996, Urology.

[55]  J. Nickel,et al.  Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. , 1996, The Journal of urology.

[56]  G. Ronquist,et al.  Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study. , 1996, The Journal of urology.

[57]  D. Neal,et al.  Use of terazosin in prostatodynia and validation of a symptom score questionnaire. , 1994, Urology.

[58]  P. Hanno,et al.  Amitriptyline in the treatment of interstitial cystitis. , 1994, The Urologic clinics of North America.

[59]  P. Turchi,et al.  Use of a novel non‐steroidal anti‐inflammatory drug, nimesulide, in the treatment of abacterial prostatovesiculitis , 2009, Andrologia.

[60]  T. Tammela,et al.  Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia. , 1993, The Journal of urology.

[61]  J. J. de la Rosette,et al.  Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. , 1992, European urology.

[62]  E. Brähler,et al.  Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median followup of 30 months. , 1991, The Journal of urology.

[63]  F. B. Tormo,et al.  Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control. , 1988, The Journal of urology.

[64]  G. Sant,et al.  Prostatodynia: clinical and urodynamic characteristics. , 1983, The Journal of urology.

[65]  Barbalias Ga,et al.  Prostatitis: bacterial, nonbacterial, and prostatodynia. , 1983 .

[66]  D. Bach,et al.  How important are prostaglandins in the urology of man? , 1982, Urologia internationalis.

[67]  J. L. Opitz,et al.  Prostatosis, prostatitis or pelvic floor tension myalgia? , 1979, The Journal of urology.

[68]  T. Stamey,et al.  Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? , 1978, The Journal of urology.